“We have two main goals.
The first is to give healthcare professionals, doctors, and nurses the ability to use either of the two vaccines for both the first injection and the second to make it easier.
Otherwise, they need to know which vaccine was used the first time.
And so the use of vaccines is greatly simplified.
The second goal is to improve efficiency whenever possible.
By combining the two vaccines, it is possible to achieve even greater effectiveness by increasing the stimulation of the immune system, ”he said.
He noted that all companies are fighting the virus, trying to create a vaccine first.
“But in reality, we will need a lot of vaccines, since there is no company that alone is capable of producing enough drug for the whole world.
So we will need many, many different vaccines so that we can vaccinate as many people around the world as possible in a very short time.
Some of these vaccines need to be easy to administer and inexpensive because low- and middle-income countries cannot afford the expensive drugs, ”Sorio added.
Earlier, the Gamaleya Center, AstraZeneca, RDIF and R-Pharm adopted a memorandum of cooperation in the fight against coronavirus.
On December 11, AstraZeneca accepted the proposal of the Sputnik V vaccine developers for a combination of medicines.